Mandate

Stora Enso increases its holding in Cellutech

October 29, 2018 M&A

Vinge has advised Cellutech in connection with the minority shareholder Stora Enso acquiring all shares in the company.

Cellutech was founded in 2013 and consists of an active team with eight scientists and researchers who act as a link between academia and industry.

Cellutech was started in order to develop ideas from high class technology research at SweTree Technologies and Wallenberg Wood Science Center to commercially successful technology and products.

Vinge’s team consisted of Johan Winnerblad and Kristina Ekberg.
 

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025